search button

Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma.

  • Authors:
    • I Takanami

  • View Affiliations

  • Published online on: March 1, 1999     https://doi.org/10.3892/or.6.2.341
  • Pages: 341-345
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The prognostic significance of Thomsen-Frienden-reich antigen (T antigen) expression was investigated in 126 patients with pulmonary adenocarcinoma by immunohistochemical staining of tumor specimens with a monoclonal antibody specific for T antigen. T antigen immunoreactivity was detected in tumor tissue from 60 (48%) patients. T antigen expression did not correlate with gender, tumor size, presence of lymph node or distant metastasis, stage of disease, or degree of tumor cell differentiation. However, the presence of T antigen immunoreactivity correlated significantly with overall survival. The presence of T antigen immunoreactivity in tumor cells is a useful marker of prognosis in patients with pulmonary adenocarcinoma.

Related Articles

Journal Cover

Mar-Apr 1999
Volume 6 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 4.2
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 8.4
  • CiteScore Rank: Q1: #68/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.786
  • SCImago Journal Rank (SJR): 0.812
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Takanami I: Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma.. Oncol Rep 6: 341-345, 1999
APA
Takanami, I. (1999). Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma.. Oncology Reports, 6, 341-345. https://doi.org/10.3892/or.6.2.341
MLA
Takanami, I."Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma.". Oncology Reports 6.2 (1999): 341-345.
Chicago
Takanami, I."Expression of Thomsen-Friedenreich antigen as a marker of poor prognosis in pulmonary adenocarcinoma.". Oncology Reports 6, no. 2 (1999): 341-345. https://doi.org/10.3892/or.6.2.341